These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Worsening of Callus Hyperplasia after Bisphosphonate Treatment in Type V Osteogenesis Imperfecta.
    Author: Ranganath P, Stephen J, Iyengar R, Phadke SR.
    Journal: Indian Pediatr; 2016 Mar; 53(3):250-2. PubMed ID: 27029692.
    Abstract:
    BACKGROUND: Type V osteogenesis imperfecta is characterized by hyperplastic callus formation and interosseus membrane calcification. CASE CHARACTERISTICS: A 16-year-old boy who presented with history of recurrent fractures, had hard persistent swellings at fracture sites, and had radiographic features of hyperplastic callus and interosseus membrane calcification. OUTCOME: Sequence analysis of the IFITM5 gene revealed the c.-14 C>T mutation. The patient had significant exacerbation of callus hyperplasia after initiation of bisphosphonate therapy, which reversed following cessation of the treatment. MESSAGE: Bisphosphonates may exacerbate callus hyperplasia, and may therefore have to be used with caution in patients with type V osteogenesis imperfecta.
    [Abstract] [Full Text] [Related] [New Search]